Dow Down 0.39% Nasdaq Up 0.14%

Poniard Pharmaceuticals, Inc. (PARD)

-Other OTC
0.34 0.00(0.00%) Aug 28
Prev Close:0.34
Open:0.34
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:2.07
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.20 - 0.56
Volume:25
Avg Vol (3m):1,160
Market Cap:509.51K
P/E (ttm):N/A
EPS (ttm):-3.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PARD

Comparison

Symbol% ChgMkt Cap
PARD 0.00%509.51K
BMYDown 0.05%83.93B
IMGNUp 5.58%1.07B
SNYUp 0.51%144.28B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (Mar-11) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback